Last reviewed · How we verify

NCT05575193

Acupressure on Uremic Pruritus and Sleep Quality Among Patients Receiving Hemodialysis

Completed NA Last updated 23 March 2023
What this trial tests

NA trial testing Acupressure in Hemodialysis in 44 participants. Completed in 31 December 2022.

Timeline
15 March 2021
Primary endpoint
31 December 2022
31 December 2022

Quick facts

Lead sponsorNational Taipei University of Nursing and Health Sciences
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment44
Start date15 March 2021
Primary completion31 December 2022
Estimated completion31 December 2022
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

National Taipei University of Nursing and Health Sciences

Who can join

Adults 20 to 60, any sex, with Hemodialysis or Uremic Pruritus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The research is to explore the effect of acupressure on uremic pruritus and sleep quality among patients receiving hemodialysis. The research method adopts the experimental research method using randomization. The patients receiving the intervention of acupressure are in the experimental group, while those who do not receive it are in the control group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Acupressure

Trials testing the same drug.

Other recruiting trials for Hemodialysis

Currently open trials in the same condition.

Other National Taipei University of Nursing and Health Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05575193.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing